Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 511.00
+2.00 (0.39%)
At close: Sep 16, 2025
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 116.79 billion as of September 17, 2025. Its market cap has increased by 219.36% in one year.
Market Cap
116.79B
Enterprise Value
111.98B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
511.00
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 116.79B, an increase of 765.77%. That is a compound annual growth rate of 168.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 116.79B | 214.68% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 278.04B |
| JD Health International | 222.02B |
| Hansoh Pharmaceutical Group Company | 215.52B |
| Innovent Biologics | 167.59B |
| Sino Biopharmaceutical | 154.34B |
| WuXi Biologics | 148.25B |
| Akeso | 124.81B |
| CSPC Pharmaceutical Group | 118.33B |